Skip to main content
Erschienen in: Clinical Rheumatology 11/2009

01.11.2009 | Brief Report

Evaluation of pathergy test positivity in familial Mediterranean fever patients and comparison of clinical manifestations of FMF with Behçet’s disease

verfasst von: Fatma Aydin, Tekin Akpolat, Nilgun Senturk, Hasan Bagci, Ahmet Yasar Turanli

Erschienen in: Clinical Rheumatology | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Familial Mediterranean fever (FMF) shares a number of features with Behçet’s disease (BD), such as their common ethnic origin, etiopathogenetic mechanisms, symptoms, and treatment. Pathergy reaction is accepted as a major criterion in BD. We aimed to determine the frequency of pathergy positivity in FMF patients and compared clinical features between FMF and BD. Pathergy test was performed in patients with FMF, BD, and healthy controls. Diagnostic criteria for FMF and BD were screened in both groups. None of the FMF patients or healthy controls yielded positive pathergy test. Pathergy test was positive in 13 out of 31 (41.9%) of the patients with BD. None of the FMF patients fulfilled the International Study Group criteria for BD. None of the BD patients fulfilled the Livneh diagnostic criteria for FMF. BD and FMF are associated with neutrophilic dermatoses and neutrophil hyper-reactivity. Although pathergy test and erysipelas-like erythema share some histological findings, pathergy test was negative among FMF patients.
Literatur
1.
Zurück zum Zitat Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef
2.
Zurück zum Zitat Ghate JV, Jorizzo JL (1999) Behçet’s disease and complex aphthosis. J Am Acad Dermatol 40(1):1–18PubMedCrossRef Ghate JV, Jorizzo JL (1999) Behçet’s disease and complex aphthosis. J Am Acad Dermatol 40(1):1–18PubMedCrossRef
3.
Zurück zum Zitat Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behçet’s disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29(5):286–295PubMedCrossRef Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behçet’s disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29(5):286–295PubMedCrossRef
4.
Zurück zum Zitat Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanç M, Capo C (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20(9):1544–1549PubMed Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanç M, Capo C (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20(9):1544–1549PubMed
5.
Zurück zum Zitat Yigit S, Bagci H, Ozkaya O, Ozdamar K, Cengiz K, Akpolat T (2008) MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience. J Rheumatol 35(1):106–113PubMed Yigit S, Bagci H, Ozkaya O, Ozdamar K, Cengiz K, Akpolat T (2008) MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience. J Rheumatol 35(1):106–113PubMed
6.
Zurück zum Zitat Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A (2007) Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 36(1):48–52PubMedCrossRef Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A (2007) Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 36(1):48–52PubMedCrossRef
7.
Zurück zum Zitat Renda MC, Civitavecchia G, Fabiano C, Sammarco P, Cottone M (2008) Familial Mediterranean fever gene (MEVF) mutations in Crohn’s disease in a Mediterranean area. Inflamm Bowel Dis 14(9):1313PubMedCrossRef Renda MC, Civitavecchia G, Fabiano C, Sammarco P, Cottone M (2008) Familial Mediterranean fever gene (MEVF) mutations in Crohn’s disease in a Mediterranean area. Inflamm Bowel Dis 14(9):1313PubMedCrossRef
8.
Zurück zum Zitat Miyoshi T, Yamashita K, Ohno T, Izumi T, Takaori-Kondo A, Sasada M, Uchiyama T (2008) Familial Mediterranean fever gene as a possible modifier of Sweet syndrome with chronic myelogenous leukemia. Acta Haematol 120(1):57–62PubMedCrossRef Miyoshi T, Yamashita K, Ohno T, Izumi T, Takaori-Kondo A, Sasada M, Uchiyama T (2008) Familial Mediterranean fever gene as a possible modifier of Sweet syndrome with chronic myelogenous leukemia. Acta Haematol 120(1):57–62PubMedCrossRef
9.
Zurück zum Zitat Ozdogan H, Arisoy N, Kasapcapur O, Sever L, Calişkan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed Ozdogan H, Arisoy N, Kasapcapur O, Sever L, Calişkan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed
10.
Zurück zum Zitat Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, Turgan C, Turkmen A, Akpolat I, Danaci M, Besbas N, Akpolat T (2001) Polyarteritis nodosa in patients with familial Mediterranean fever (FMF): a concomitant disease or a feature of FMF. Semin Arthritis Rheum 30:281–287PubMedCrossRef Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, Turgan C, Turkmen A, Akpolat I, Danaci M, Besbas N, Akpolat T (2001) Polyarteritis nodosa in patients with familial Mediterranean fever (FMF): a concomitant disease or a feature of FMF. Semin Arthritis Rheum 30:281–287PubMedCrossRef
11.
Zurück zum Zitat Inaloz HS, Evereklioglu C, Unal B, Kirtak N, Eralp A, Inaloz SS (2004) The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet’s syndrome. J Eur Acad Dermatol Venereol 18(1):56–61PubMedCrossRef Inaloz HS, Evereklioglu C, Unal B, Kirtak N, Eralp A, Inaloz SS (2004) The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet’s syndrome. J Eur Acad Dermatol Venereol 18(1):56–61PubMedCrossRef
12.
Zurück zum Zitat International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080 International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
13.
Zurück zum Zitat Gul A, Esin S, Dilsen N, Konice M, Wigzell H, Biberfeld P (1995) Immunohistology of skin pathergy reaction in Behçet’s disease. Br J Dermatol 132:901–907PubMed Gul A, Esin S, Dilsen N, Konice M, Wigzell H, Biberfeld P (1995) Immunohistology of skin pathergy reaction in Behçet’s disease. Br J Dermatol 132:901–907PubMed
14.
Zurück zum Zitat Hatemi I, Hatemi G, Celik AF, Melikoglu M, Arzuhal N, Mat C, Ozyazgan Y, Yazici H (2008) Frequency of pathergy phenomenon and other features of Behçet’s syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol 26:91–95 Hatemi I, Hatemi G, Celik AF, Melikoglu M, Arzuhal N, Mat C, Ozyazgan Y, Yazici H (2008) Frequency of pathergy phenomenon and other features of Behçet’s syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol 26:91–95
15.
Zurück zum Zitat Lindberg-Larsen R, Fogh K (2009) Traumatic pyoderma gangrenosum of the face: pathergy development after bike accident. Dermatology 218(3):272–274PubMedCrossRef Lindberg-Larsen R, Fogh K (2009) Traumatic pyoderma gangrenosum of the face: pathergy development after bike accident. Dermatology 218(3):272–274PubMedCrossRef
16.
Zurück zum Zitat Bi XL, Gu J, Yan M, Gao CF (2008) A case of Sweet’s syndrome with slack skin and pathergy phenomenon. Int J Dermatol 47:842–844PubMedCrossRef Bi XL, Gu J, Yan M, Gao CF (2008) A case of Sweet’s syndrome with slack skin and pathergy phenomenon. Int J Dermatol 47:842–844PubMedCrossRef
17.
Zurück zum Zitat Barzilai A, Langevitz P, Goldberg I, Kopolovic J, Livneh A, Pras M, Trau H (2000) Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 42:791–795PubMedCrossRef Barzilai A, Langevitz P, Goldberg I, Kopolovic J, Livneh A, Pras M, Trau H (2000) Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 42:791–795PubMedCrossRef
18.
Zurück zum Zitat Livneh A, Langevitz E, Zemer D, Zacks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1884–1890CrossRef Livneh A, Langevitz E, Zemer D, Zacks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1884–1890CrossRef
19.
Zurück zum Zitat Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 127:2243–2253PubMedCrossRef Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 127:2243–2253PubMedCrossRef
20.
Zurück zum Zitat Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H (1999) Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever. J Rheumatol 26:1983–1986PubMed Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H (1999) Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever. J Rheumatol 26:1983–1986PubMed
21.
Zurück zum Zitat Nazzaro P (1966) Cutaneous manifestations of Behçet’s disease. In: Monacelli M, Nazzaro P (eds) International Symposium on Behçet’s Disease, Rome, Italy, 1996. Karger, New York, pp 15–41 Nazzaro P (1966) Cutaneous manifestations of Behçet’s disease. In: Monacelli M, Nazzaro P (eds) International Symposium on Behçet’s Disease, Rome, Italy, 1996. Karger, New York, pp 15–41
22.
23.
Zurück zum Zitat Jorizzo JL, Solomon AR, Cavallo T (1985) Behçet’s syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 109:747–751PubMed Jorizzo JL, Solomon AR, Cavallo T (1985) Behçet’s syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 109:747–751PubMed
24.
Zurück zum Zitat Krause I, Molad Y, Mitrani M, Weinberger A (2000) Pathergy reaction in Behçet’s disease: lack of correlation with mucocutaneous manifestations and systemic disease expression. Clin Exp Rheumatol 18:71–74PubMed Krause I, Molad Y, Mitrani M, Weinberger A (2000) Pathergy reaction in Behçet’s disease: lack of correlation with mucocutaneous manifestations and systemic disease expression. Clin Exp Rheumatol 18:71–74PubMed
25.
Zurück zum Zitat Chang HK, Cheon KS (2002) The clinical significance of a pathergy reaction in patients with Behcet’s disease. J Korean Med Sci 17:371–374PubMed Chang HK, Cheon KS (2002) The clinical significance of a pathergy reaction in patients with Behcet’s disease. J Korean Med Sci 17:371–374PubMed
Metadaten
Titel
Evaluation of pathergy test positivity in familial Mediterranean fever patients and comparison of clinical manifestations of FMF with Behçet’s disease
verfasst von
Fatma Aydin
Tekin Akpolat
Nilgun Senturk
Hasan Bagci
Ahmet Yasar Turanli
Publikationsdatum
01.11.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 11/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1237-5

Weitere Artikel der Ausgabe 11/2009

Clinical Rheumatology 11/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.